The Epstein-Barr Virus SM Protein Induces STAT1 and Interferon-stimulated Gene Expression
Overview
Affiliations
Viruses utilize numerous mechanisms to counteract the host's immune response. Interferon production is a major component of the host antiviral response. Many viruses, therefore, produce proteins or RNA molecules that inhibit interferon-induced signal transduction pathways and their associated antiviral effects. Surprisingly, some viruses directly induce expression of interferon-induced genes. SM, an early lytic Epstein-Barr virus (EBV) nuclear protein, was found to specifically increase the expression of several genes (interferon-stimulated genes) that are known to be strongly induced by alpha/beta interferons. SM does not directly stimulate alpha/beta interferon secretion but instead induces STAT1, an intermediate step in the interferon signaling pathway. SM is a posttranscriptional activator of gene expression and increases STAT1 mRNA accumulation, particularly that of the functionally distinct STAT1beta splice variant. SM expression in B lymphocytes is associated with decreased cell proliferation but does not decrease cell viability or induce cell cycle arrest. These results indicate that EBV can specifically induce cellular genes that are normally physiological targets of interferon by inducing components of cytokine signaling pathways. Our findings therefore suggest that some aspects of the interferon response may be positively modulated by infecting viruses.
Jirau-Colon H, Jimenez-Velez B Toxics. 2024; 12(4).
PMID: 38668515 PMC: 11054084. DOI: 10.3390/toxics12040292.
Dorothea M, Xie J, Yiu S, Chiang A Cancers (Basel). 2023; 15(7).
PMID: 37046781 PMC: 10093119. DOI: 10.3390/cancers15072120.
Zhang Y, Gargan S, Roche F, Frieman M, Stevenson N Viruses. 2022; 14(4).
PMID: 35458397 PMC: 9032603. DOI: 10.3390/v14040667.
Epstein-Barr Virus Enhances Cancer-Specific Aberrant Splicing of TSG101 Pre-mRNA.
Chua H, Kameyama T, Mayeda A, Yeh T Int J Mol Sci. 2022; 23(5).
PMID: 35269659 PMC: 8910672. DOI: 10.3390/ijms23052516.
Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies.
Francies F, Dlamini Z Cells. 2021; 10(2).
PMID: 33530521 PMC: 7910916. DOI: 10.3390/cells10020239.